Endocrinology
Endocrinology and Metabolic Disorder Clinical Trials Experience in Indonesia
Our trial experiences cover a wide range of indications, including but not limited to:
-
Diabetes
-
Prediabetes
-
Obesity and weight management
-
Other metabolic disorders
Are you ready to collaborate with your next endocrinology CRO? Contact us today.
Our Clinical Trials in Numbers
10+
Pharmaceutical and biotech companies.
2,000+
Patients enrolled.
12+
Endocrinology clinical trials managed.
Complete Services for Sponsor's Endocrinology and Metabolic Disease Clinical Trials
Our services are designed to suit with your clinical trial, this includes:
-
Finding Strategic Site and Patients
Endocrinology trials often require large patient populations. We identify and manage the most promising sites for your study and leverage our network of experienced Principal Investigators (PIs) to run the trial. Besides, we are working with sites to develop and implement strategic recruitment plans to ensure fast and efficient patient recruitment.
-
Regulatory Compliance and EC Submissions
Equilab has a strong relationship with BPOM and the experts to manage all submissions to Ethics Committees (EC) and BPOM, to secure Sponsor’s study approvals.
-
Study Monitoring
Our experienced Clinical Research Associates (CRAs) perform regular monitoring visits to maintain compliance with the protocol, adhere to Good Clinical Practice (GCP) guidelines, and ensure the integrity and quality of your data from site initiation through closeout.
-
Strong Project and Site Management
Equilab's dedicated Clinical Project Managers (CPMs) are your assurance of a seamless and successful clinical trial. With over 20 years of collective experience, our team proactively manages every aspect of your study to ensure strict adherence to protocol, timelines, and quality standards. We maintain strong communication with both the clinical sites and the sponsor, providing real-time updates and transparent coordination. This hands-on, expert approach ensures smooth clinical trial progress and allows you to focus on your research goals in Indonesia.
Overview
Your Solution for Endocrinology and Metabolic Disorder Clinical Trials in Indonesia.
Indonesia faces a significant public health challenge with the rising prevalence of metabolic disorders, particularly diabetes mellitus. As one of the top ten countries globally for diabetes cases, with a projected 28,5 million sufferers by 2050, there is a critical need for innovative treatments.
Equilab has managed many endocrinology clinical trials, particularly diabetes. Our extensive network of sites and investigators provides access to a large, diverse, and often treatment-naïve patient pool. This makes Indonesia an ideal and cost-effective environment for conducting robust diabetes and metabolic studies, ultimately providing Indonesian patients with access to life-changing, innovative therapies.